Addex Therapeutics's market cap is currently $15.05M. The company's EPS TTM is $-0.02; its P/E ratio is 0.77; Addex Therapeutics is scheduled to report earnings on September 30, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
